Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
26/11/2007 | 19:10 | Edgar (US Regulatory) | Idera Pharmaceuticals, Inc. - Current report filing (8-K) | AMEX:IDP | Idera Pharmaceuticals |
21/11/2007 | 23:52 | Edgar (US Regulatory) | Idera Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | AMEX:IDP | Idera Pharmaceuticals |
16/11/2007 | 22:31 | Edgar (US Regulatory) | Idera Pharmaceuticals, Inc. - Securities Registration: Employee Benefit Plan (S-8) | AMEX:IDP | Idera Pharmaceuticals |
13/11/2007 | 14:15 | Edgar (US Regulatory) | Idera Pharmaceuticals, Inc. (Other) (10-Q) | AMEX:IDP | Idera Pharmaceuticals |
09/11/2007 | 15:33 | Edgar (US Regulatory) | Idera Pharmaceuticals, Inc. - Statement of Ownership (SC 13G) | AMEX:IDP | Idera Pharmaceuticals |
27/09/2007 | 20:42 | Edgar (US Regulatory) | Idera Pharmaceuticals, Inc. (Other) (4) | AMEX:IDP | Idera Pharmaceuticals |
27/09/2007 | 20:39 | Edgar (US Regulatory) | Idera Pharmaceuticals, Inc. (Other) (3) | AMEX:IDP | Idera Pharmaceuticals |
27/09/2007 | 14:24 | Edgar (US Regulatory) | Idera Pharmaceuticals, Inc. (Other) (8-K) | AMEX:IDP | Idera Pharmaceuticals |
14/08/2007 | 14:00 | Business Wire | Idera Pharmaceuticals Announces Publication of Preclinical Data on Toll-Like Receptor 7 and 8 Agonists | AMEX:IDP | Idera Pharmaceuticals |
03/08/2007 | 14:00 | Business Wire | Idera Pharmaceuticals to Present at Canaccord Adams 27th Annual Global Growth Conference | AMEX:IDP | Idera Pharmaceuticals |
01/08/2007 | 14:30 | Business Wire | Idera Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2007 | AMEX:IDP | Idera Pharmaceuticals |
17/07/2007 | 15:23 | Business Wire | Idera Pharmaceuticals Announces Publication of Study of Toll-Like Receptor 9 Agonist in Combination with Avastin(R) in Preclinic | AMEX:IDP | Idera Pharmaceuticals |
17/07/2007 | 14:00 | Business Wire | Idera Pharmaceuticals Presents Preclinical Data of Toll-Like Receptor Antagonists in Rheumatoid Arthritis Models | AMEX:IDP | Idera Pharmaceuticals |
21/05/2007 | 15:20 | Business Wire | Idera Pharmaceuticals Announces Chief Financial Officer to Leave Company Effective July 31, 2007 | AMEX:IDP | Idera Pharmaceuticals |
15/05/2007 | 14:00 | Business Wire | Idera Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2007 | AMEX:IDP | Idera Pharmaceuticals |
10/05/2007 | 14:00 | Business Wire | Idera Pharmaceuticals to Present at Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference | AMEX:IDP | Idera Pharmaceuticals |
03/05/2007 | 14:00 | Business Wire | Idera Pharmaceuticals to Present at BIO Business Forum and Participate in Toll-Like Receptor Panel at BIO 2007 | AMEX:IDP | Idera Pharmaceuticals |
18/04/2007 | 15:30 | Business Wire | Idera Pharmaceuticals Announces Presentations of Preclinical Data on New Potential Oncology Applications of its TLR9 Agonists at | AMEX:IDP | Idera Pharmaceuticals |
05/04/2007 | 14:00 | Business Wire | Idera Pharmaceuticals to Present at CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference | AMEX:IDP | Idera Pharmaceuticals |
06/03/2007 | 14:00 | Business Wire | Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2006 Financial Results | AMEX:IDP | Idera Pharmaceuticals |
06/03/2007 | 13:30 | Business Wire | Idera Pharmaceuticals Announces Extension of Research Collaboration on Asthma and Allergy | AMEX:IDP | Idera Pharmaceuticals |
22/01/2007 | 15:00 | PR Newswire (US) | American Stock Exchange to Host First Annual Healthcare Conference in Boston on February 8, 2007 | AMEX:IDP | Idera Pharmaceuticals |
11/12/2006 | 14:00 | Business Wire | Merck & Co., Inc. and Idera Pharmaceuticals Sign Collaboration Agreement Incorporating Idera's Toll-like Receptor Agonists in Me | AMEX:IDP | Idera Pharmaceuticals |
30/11/2006 | 14:15 | Business Wire | Idera Pharmaceuticals to Present at the BMO Capital Markets Focus on Healthcare Conference | AMEX:IDP | Idera Pharmaceuticals |
14/11/2006 | 14:00 | Business Wire | Idera Pharmaceuticals Announces Financial Results for the Three and Nine Months Ended September 30, 2006 | AMEX:IDP | Idera Pharmaceuticals |
10/11/2006 | 16:35 | Business Wire | Idera Presents Preclinical Data on Novel Class of Toll-Like Receptor Antagonists | AMEX:IDP | Idera Pharmaceuticals |
01/11/2006 | 14:15 | Business Wire | Idera Pharmaceuticals to Present at Rodman & Renshaw 8th Annual Healthcare Conference | AMEX:IDP | Idera Pharmaceuticals |
24/10/2006 | 14:30 | Business Wire | Idera to Draw Down $4 Million under Existing Equity Vehicle | AMEX:IDP | Idera Pharmaceuticals |
04/10/2006 | 15:25 | Business Wire | Idera Pharmaceuticals Announces Issuance of a US Patent for Method of Inducing an Immune Response through Administration of Immu | AMEX:IDP | Idera Pharmaceuticals |
13/09/2006 | 14:30 | Business Wire | Idera Pharmaceuticals Announces the Issuance of US Patent Claiming Compounds that Target Toll-like Receptor 9 | AMEX:IDP | Idera Pharmaceuticals |